SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (3057)12/2/1997 10:41:00 AM
From: PAL  Read Replies (1) | Respond to of 6136
 
AGPH is not AOL. If AOL has a bad news, it can spin it as a positive development such that the stock will go up. If there is good news the spin is even faster. Can you imagine that AOL with no earnings commands $ 78/sh while AGPH with solid earnings trades at $ 33/sh? Maybe AGPH should hire AOL PR. Underpromised and overdelivered just like nice guys finish last. It is a jungle out there.



To: David S. who wrote (3057)12/2/1997 1:32:00 PM
From: James Silverman  Respond to of 6136
 
Nice call David. I would add that this was not a surprise to everyone.
The far bigger news was Roche halting their cancer alliance.

$70 by November :-)



To: David S. who wrote (3057)12/3/1997 11:56:00 AM
From: Mr. Pink  Respond to of 6136
 
you are very wise re agph. mr. pink hopes you were SSSSSSSSSHort

Danl


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News